Benchmark Lowers Biofrontera (NASDAQ:BFRI) Price Target to $2.75
Biofrontera (NASDAQ:BFRI – Get Free Report) had its price target lowered by analysts at Benchmark from $7.00 to $2.75 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Benchmark’s target price would indicate a potential upside of 317.30% from the company’s current price. Biofrontera Stock Down […]
Biofrontera (NASDAQ:BFRI – Get Free Report) had its price target lowered by analysts at Benchmark from $7.00 to $2.75 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Benchmark’s target price would indicate a potential upside of 317.30% from the company’s current price. Biofrontera Stock Down […]
